208 related articles for article (PubMed ID: 11159969)
21. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
[TBL] [Abstract][Full Text] [Related]
22. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM(197) conjugate vaccines in a murine model.
Mawas F; Feavers IM; Corbel MJ
Vaccine; 2000 Dec; 19(9-10):1159-66. PubMed ID: 11137252
[TBL] [Abstract][Full Text] [Related]
23. A novel phosphocholine antigen protects both normal and X-linked immune deficient mice against Streptococcus pneumoniae. Comparison of the 6-O-phosphocholine hydroxyhexanoate-conjugate with other phosphocholine-containing vaccines.
Fischer RT; Longo DL; Kenny JJ
J Immunol; 1995 Apr; 154(7):3373-82. PubMed ID: 7897220
[TBL] [Abstract][Full Text] [Related]
24. Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.
Safari D; Dekker HA; Joosten JA; Michalik D; de Souza AC; Adamo R; Lahmann M; Sundgren A; Oscarson S; Kamerling JP; Snippe H
Infect Immun; 2008 Oct; 76(10):4615-23. PubMed ID: 18678667
[TBL] [Abstract][Full Text] [Related]
25. Effect of individual conjugate dose on immunogenicity of type 6B pneumococcal polysaccharide-N. meningitidis outer membrane protein complex conjugate vaccines in infant rhesus monkeys.
McNeely TB; Liu X; Bringman T; Donnelly JJ
Vaccine; 2000 Jun; 18(25):2808-16. PubMed ID: 10812223
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity in mice of pneumococcal glycoconjugate vaccines using pneumococcal protein carriers.
Lee CJ; Wang TR; Frasch CE
Vaccine; 2001 Apr; 19(23-24):3216-25. PubMed ID: 11312018
[TBL] [Abstract][Full Text] [Related]
27. Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.
Jansen WT; Gootjes J; Zelle M; Madore DV; Verhoef J; Snippe H; Verheul AF
Clin Diagn Lab Immunol; 1998 Sep; 5(5):703-10. PubMed ID: 9729539
[TBL] [Abstract][Full Text] [Related]
28. Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen.
Wang Y; Wen Z; Pan X; Briles DE; He Y; Zhang JR
Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29891544
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate.
Kabanova A; Margarit I; Berti F; Romano MR; Grandi G; Bensi G; Chiarot E; Proietti D; Swennen E; Cappelletti E; Fontani P; Casini D; Adamo R; Pinto V; Skibinski D; Capo S; Buffi G; Gallotta M; Christ WJ; Campbell AS; Pena J; Seeberger PH; Rappuoli R; Costantino P
Vaccine; 2010 Dec; 29(1):104-14. PubMed ID: 20870056
[TBL] [Abstract][Full Text] [Related]
30. A murine model for the study of immune memory in response to pneumococcal conjugate vaccination.
Moreno RL; Sampson JS; Romero-Steiner S; Wong B; Johnson SE; Ades E; Carlone GM
Vaccine; 2004 Aug; 22(23-24):3069-79. PubMed ID: 15297057
[TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
32. A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice.
Buchwald UK; Lees A; Steinitz M; Pirofski LA
Infect Immun; 2005 Jan; 73(1):325-33. PubMed ID: 15618169
[TBL] [Abstract][Full Text] [Related]
33. Investigation of non-typeable Haemophilus influenzae outer membrane protein P6 as a new carrier for lipooligosaccharide conjugate vaccines.
Wu T; Chen J; Murphy TF; Green BA; Gu XX
Vaccine; 2005 Oct; 23(44):5177-85. PubMed ID: 16039021
[TBL] [Abstract][Full Text] [Related]
34. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.
Henckaerts I; Durant N; De Grave D; Schuerman L; Poolman J
Vaccine; 2007 Mar; 25(13):2518-27. PubMed ID: 17034907
[TBL] [Abstract][Full Text] [Related]
35. Synthetic Library of Oligosaccharides Derived from the Capsular Polysaccharide of
Mettu R; Lih YH; Vulupala HR; Chen CY; Hsu MH; Lo HJ; Liao KS; Cheng YY; Chiu CH; Wu CY
ACS Infect Dis; 2022 Mar; 8(3):626-634. PubMed ID: 35171577
[No Abstract] [Full Text] [Related]
36. Immunization with the RrgB321 fusion protein protects mice against both high and low pilus-expressing Streptococcus pneumoniae populations.
Moschioni M; De Angelis G; Harfouche C; Bizzarri E; Filippini S; Mori E; Mancuso G; Doro F; Barocchi MA; Ruggiero P; Masignani V
Vaccine; 2012 Feb; 30(7):1349-56. PubMed ID: 22210141
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs.
van den Dobbelsteen GP; van Dijken HH; Pillai S; van Alphen L
Vaccine; 2007 Mar; 25(13):2491-6. PubMed ID: 17023098
[TBL] [Abstract][Full Text] [Related]
38. Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay.
Concepcion NF; Frasch CE
Clin Diagn Lab Immunol; 2001 Mar; 8(2):266-72. PubMed ID: 11238206
[TBL] [Abstract][Full Text] [Related]
39. A semisynthetic
Schumann B; Hahm HS; Parameswarappa SG; Reppe K; Wahlbrink A; Govindan S; Kaplonek P; Pirofski LA; Witzenrath M; Anish C; Pereira CL; Seeberger PH
Sci Transl Med; 2017 Mar; 9(380):. PubMed ID: 28275152
[TBL] [Abstract][Full Text] [Related]
40. Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice.
Benaissa-Trouw B; Lefeber DJ; Kamerling JP; Vliegenthart JF; Kraaijeveld K; Snippe H
Infect Immun; 2001 Jul; 69(7):4698-701. PubMed ID: 11402020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
